Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement

Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement

Insulin degludec/insulin aspart (IDegAsp) is a modern coformulation of ultra-long-acting basal insulin degludec, with rapid-acting insulin aspart. IDegAsp provides effective, safe, well-tolerated glycemic control, with a low risk of hypoglycemia while allowing flexibility in meal patterns and timing...

Full description

Bibliographic Details
Main Authors: Sanjay Kalra, Zafar A Latif, Abdurrahman Comlekci, Guillermo Gonzalez Galvez, Rached Malik, Md Faruque Pathan, Ajay Kumar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Basal–bolus
basal insulin
coformulation
flexibility
hypoglycemia
insulin
insulin aspart
insulin degludec
insulin degludec/insulin aspart
premixed insulin
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=4;spage=542;epage=545;aulast=Kalra

Internet

http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=4;spage=542;epage=545;aulast=Kalra

Similar Items